Delivery Order SPE2DB20D2014-SPE2DB24FC06F
- Not listed
- This is a federal delivery order contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,044.09 firm fixed-price contract is for the delivery of Clarithromycin 500 mg tablets. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Clarithromycin 500 mg tablets and has a ceiling value of $1,294.32. The contract is a firm fixed-price, non-set-aside contract with a performance period through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of clarithromycin 500 mg tablets. The contract, valued at $4,388.49, was awarded on May 8, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation mentioned for this award. Amerisourcebergen, one of the largest pharmaceutical...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,970.54, is a Firm Fixed Price Delivery Order for the procurement of the drug Clarithromycin 500mg tablets. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of Clarithromycin 250 mg tablets. The contract has a ceiling value of $1,366.18 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 25, 2024. This contract award is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, with an ID of SPE2DB20D3101 and SPE2DB24FRGM3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,935.25, is for the delivery of 4,564,286,635 units of Clarithromycin 500 mg tablets. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 16, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,848.65 contract is for the supply of a pharmaceutical product, Clindamycin 900 mg/50 ml-D5W 50 ml. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through December 31, 2025. The...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, valued at $25,129.86. The contract is for the supply of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,397.41 Firm Fixed Price delivery order contract is for the supply of Clarithromycin 500 mg tablets, a medication used to treat various bacterial infections. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Clarithromycin 500 mg tablets. The contract has a ceiling value of $1,196.60 and a completion date of July 17, 2025. The award is not set-aside and was competitively granted. AmerisourceBergen Drug Corp, a for-profit organization, is a critical vendor for federal medical procurement, particularly supporting military and...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FC06FDelivery Order
The Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $1,525.20, is for the delivery of Clarithromycin 500 mg tablets. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 5/29/24 |